Garth Percival Greenham, a Senior Officer, acquired 1,000,000 Common Shares on a direct ownership basis at a price of $0.150 through a private transaction on April 23rd, 2020. This represents a $150,000 investment into the company's shares and an account share holdings change of 52.7%.
Solarvest BioEnergy is in the Renewable Fuels Sub Industry Group under the Energy Sector.
Solarvest BioEnergy Inc. is a Canada-based algae technology company, which is engaged in the development of specially selected algal-based production systems to produce natural-based green commercial products, such as nutritional products, oils and biologic therapies, among others. The Company is focused on developing algae strains that are rich in Docosahexaenoic Acid/ Eicosapentaenoic Acid (DHA/EPA), which are a form of Omega 3 fatty acids used by the food enhancement and Nutraceutical markets. It is also focuses on developing algae strains that can be used to produce proteins with the first such target being a therapeutic that has use in human and animal orthopedic surgery and genetically modified algae strain that can be used to produce hydrogen. It is also focused on custom producing organic chemical-free Omega 3s and other nutritional oils. Its subsidiaries include Phycobiologics (Europe) Limited, Phyco Hydrogen Inc. and Solarvest (P.E.I.) Inc.
No Comments